Alterations of Renal Phenotype and Gene Expression Profiles Due to Protein Overload in NOD-related Mouse Strains

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2005 Dec 24

PMID 16371158

Citations 4

Authors

Karen H S Wilson

Richard A McIndoe

Sarah Eckenrode

Laurence Morel

Anupam Agarwal

Byron P Croker

Jin-Xiong She

Affiliations

Soon will be listed here.

Abstract

Background: Despite multiple causes, Chronic Kidney Disease is commonly associated with proteinuria. A previous study on Non Obese Diabetic mice (NOD), which spontaneously develop type 1 diabetes, described histological and gene expression changes incurred by diabetes in the kidney. Because proteinuria is coincident to diabetes, the effects of proteinuria are difficult to distinguish from those of other factors such as hyperglycemia. Proteinuria can nevertheless be induced in mice by peritoneal injection of Bovine Serum Albumin (BSA). To gain more information on the specific effects of proteinuria, this study addresses renal changes in diabetes resistant NOD-related mouse strains (NON and NOD.B10) that were made to develop proteinuria by BSA overload.

Methods: Proteinuria was induced by protein overload on NON and NOD.B10 mouse strains and histology and microarray technology were used to follow the kidney response. The effects of proteinuria were assessed and subsequently compared to changes that were observed in a prior study on NOD diabetic nephropathy.

Results: Overload treatment significantly modified the renal phenotype and out of 5760 clones screened, 21 and 7 kidney transcripts were respectively altered in the NON and NOD.B10. Upregulated transcripts encoded signal transduction genes, as well as markers for inflammation (Calmodulin kinase beta). Down-regulated transcripts included FKBP52 which was also down-regulated in diabetic NOD kidney. Comparison of transcripts altered by proteinuria to those altered by diabetes identified mannosidase 2 alpha 1 as being more specifically induced by proteinuria.

Conclusion: By simulating a component of diabetes, and looking at the global response on mice resistant to the disease, by virtue of a small genetic difference, we were able to identify key factors in disease progression. This suggests the power of this approach in unraveling multifactorial disease processes.

Citing Articles

Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients.

Kreepala C, Panpruang P, Yodprom R, Piyajarawong T, Wattanavaekin K, Danjittrong T Kidney Res Clin Pract. 2021; 40(2):263-271.

PMID: 34162050 PMC: 8237118. DOI: 10.23876/j.krcp.20.190.

Genetic analysis of intracapillary glomerular lipoprotein deposits in aging mice.

Noordmans G, Huang Y, Savage H, van Dijk M, Schaart G, van den Bergh Weerman M PLoS One. 2014; 9(10):e111308.

PMID: 25353171 PMC: 4213026. DOI: 10.1371/journal.pone.0111308.

Discovery of genes related to diabetic nephropathy in various animal models by current techniques.

Wada J, Sun L, Kanwar Y Contrib Nephrol. 2011; 169:161-174.

PMID: 21252517 PMC: 3697089. DOI: 10.1159/000313951.

Role of ClC-5 in renal endocytosis is unique among ClC exchangers and does not require PY-motif-dependent ubiquitylation.

Rickheit G, Wartosch L, Schaffer S, Stobrawa S, Novarino G, Weinert S J Biol Chem. 2010; 285(23):17595-603.

PMID: 20351103 PMC: 2878524. DOI: 10.1074/jbc.M110.115600.

References

Wilson K, Eckenrode S, Li Q, Ruan Q, Yang P, Shi J . Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes. 2003; 52(8):2151-9. DOI: 10.2337/diabetes.52.8.2151. View

Mishra R, Leahy P, Simonson M . Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol. 2002; 283(5):F1151-9. DOI: 10.1152/ajprenal.00103.2002. View

Li J, Takaishi K, Cook W, McCorkle S, Unger R . Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci U S A. 2003; 100(16):9476-81. PMC: 170943. DOI: 10.1073/pnas.1133426100. View

Walls J . Relationship between proteinuria and progressive renal disease. Am J Kidney Dis. 2001; 37(1 Suppl 2):S13-6. DOI: 10.1053/ajkd.2001.20732. View

Watanabe Y, Itoh Y, Yoshida F, Koh N, Tamai H, Fukatsu A . Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice. Nephron. 1991; 58(2):210-8. DOI: 10.1159/000186417. View

Coulis C, Lee C, Nardone V, Prokipcak R . Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides. Mol Pharmacol. 2000; 57(3):485-94. DOI: 10.1124/mol.57.3.485. View

. Excerpts from the United States Renal Data Systems 2002 annual report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003; 41(4 Suppl 2):v-ix, S7-254. DOI: 10.1016/s0272-6386(03)80001-x. View

Cella N, Groner B, Hynes N . Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells. Mol Cell Biol. 1998; 18(4):1783-92. PMC: 121408. DOI: 10.1128/MCB.18.4.1783. View

Yamashita H, Nagai Y, Takamura T, Nohara E, Kobayashi K . Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metabolism. 2002; 51(4):403-8. DOI: 10.1053/meta.2002.30953. View

10.

KIMMELSTIEL P, Wilson C . Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol. 2009; 12(1):83-98.7. PMC: 1911022. View

11.

Chen A, Wei C, Sheu L, Ding S, Lee W . Induction of proteinuria by adriamycin or bovine serum albumin in the mouse. Nephron. 1995; 69(3):293-300. DOI: 10.1159/000188473. View

12.

Thongboonkerd V, Barati M, McLeish K, Benarafa C, Remold-ODonnell E, Zheng S . Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol. 2004; 15(3):650-62. DOI: 10.1097/01.asn.0000115334.65095.9b. View

13.

Tumlin J, Lea J, Swanson C, Smith C, Edge S, Someren J . Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins. J Clin Invest. 1997; 99(6):1217-23. PMC: 507935. DOI: 10.1172/JCI119278. View

14.

Yotsumoto T, Naitoh T, Kanaki T, Matsuda M, Tsuruzoe N . A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation. Metabolism. 2003; 52(12):1633-7. DOI: 10.1016/j.metabol.2003.06.002. View

15.

Hebert L, Agarwal G, Sedmak D, Mahan J, Becker W, Nagaraja H . Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int. 2000; 57(5):1962-7. DOI: 10.1046/j.1523-1755.2000.00045.x. View

16.

Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R . Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes. 2000; 49(6):1022-32. DOI: 10.2337/diabetes.49.6.1022. View

17.

Serreze D, Leiter E . Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol. 1994; 6(6):900-6. DOI: 10.1016/0952-7915(94)90011-6. View

18.

Zheng S, Noonan W, Metreveli N, Coventry S, Kralik P, Carlson E . Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes. 2004; 53(12):3248-57. DOI: 10.2337/diabetes.53.12.3248. View

19.

Baylis C, Atzpodien E, Freshour G, Engels K . Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther. 2003; 307(3):854-60. DOI: 10.1124/jpet.103.055616. View

20.

Eddy A, Kim H, Oda T, Soloway P . Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int. 2000; 58(2):618-28. DOI: 10.1046/j.1523-1755.2000.00208.x. View